CARD10 and hepatocellular carcinoma: Our previous results indicated that high expression of CARMA3 may be related to HCC cells' resistance to sorafenib, and triptolide decreased the expression of CARMA3 and induced cell injury via ROS accumulation in HCC cell lines.